Atlas FDA

Abbott RealTime CMV

FDA premarket approval P160044/S002 · decided 2019-05-15

Approval details

PMA number
P160044
Supplement
S002
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Abbott RealTime CMV
Generic name
Cytomegalovirus (cmv) dna quantitative assay
Applicant
Abbott Molecular
Date received
2019-04-10
Decision date
2019-05-15
Days to decision
35 days
Decision code
OK30
Product code
PAB
Advisory committee
Microbiology
Expedited review
No
Location
Des Plaines, IL
Statement
Implement additional QC to device accessory kits.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
simpli-COLLECT STI Test (K243410)Abbott Molecular2025-01-30
Alinity m SARS-CoV-2 AMP Kit (09N78-096); Alinity m SARS-CoV-2 CTRL Kit (09N78-086) (K241580)Abbott Molecular2024-12-06